Children’s Cancer Hospital Egypt 57357 Trains Two Ethiopian Pharmacists in Clinical Pharmacy

Tag Archives: cancer survival rates

ECN’s major partner, Children’s Cancer Hospital Egypt 57357 (CCHE) committed to hosting Meti Ayele and Yohannes Alemayehu, both prominent pharmacists based in Addis Ababa, Ethiopia, for a month-long training series pertaining to chemotherapy preparation. Both pharmacists were recommended to CCHE by the International Society of Oncology Pharmacy, noting the prime location of CCHE as well as its excellence in clinical pharmacy training.

The training was funded by the International Network for Cancer Treatment and Research (INCTR). Ms. Ayele and Mr. Alemayehu have both graduated from pharmacy school and are in the midst of working on their respective post-graduate degrees. Both are employees of Black Lion Hospital, located in Addis Ababa and known as Ethiopia’s only cancer referral center. This institution aspires to become a center of excellence comparable to CCHE in Ethiopia and solicits the support of several Ethiopian governmental institutions, many non-governmental organizations and international partners, and universities, including Georgetown University.

For Mr. Ayele, she was particularly thrilled to have had training in the application of benchmark practices concerning chemotherapy preparation and distribution. She gave much praise to the hospitals success in monitoring the effects of medication on the patients as well as the attention paid to documenting each case and educating the families of patients about the disease and its treatment. Also noted was the efficiency in communication amongst staff as to the progress and treatment of the patients.

Similarly, Mr. Alemayehu expressed his deep gratitude for his experience and stated that he promised that CCHE would not be disappointed with their renovated commitment to healthcare in Ethiopia, based on their thorough experience in the care of the clinical pharmacy department at CCHE.

Both ECN and CCHE share the principle of promoting oncology education initiatives as a means of distinguishing themselves as a center of excellence. In promoting regional education initiatives of this nature, CCHE, in collaboration with its trainees and partners, will continue to improve the cancer survival rates and treatment tactics in Egypt and beyond.

 

Dana-Farber/Children’s Hospital Cancer Center to partner with Egypt Cancer Network and Children’s Cancer Hospital Egypt

Creating Egypt-based fellowship training program for physicians from Egypt, the Middle East and North Africa Region

BOSTON – Dana-Farber/Children’s Hospital Cancer Center is announcing a partnership with the Egypt Cancer Network and Children’s Cancer Hospital Egypt in an effort to improve childhood cancer survival rates and outcomes within Egypt, the Middle East and North Africa. The organizations are collaborating to create an Egypt-based fellowship training program in pediatric oncology for physicians in those regions.

“Since beginning a twinning program between the Dana-Farber/Children’s Hospital Cancer Center and the Children’s Cancer Hospital Egypt in 2006, we have seen significant improvement in the outcome of pediatric cancer patients in Egypt,” said Mark Kieran, MD, PhD, director of medical neuro-oncology at Dana-Farber/Children’s Hospital Cancer Center and member of the medical advisory board for the Children’s Cancer Hospital Egypt 57357’s pediatric oncology fellowship program. “However, there is still a shortage of expertise and resources needed to treat children with cancer in this region.”

“The fellowship is designed to improve the childhood cancer survival rates and outcomes within Egypt, the Middle East and North Africa,” said Kieran. “This collaboration will allow the exchange of information, knowledge and experience for both doctors from the region and from the United States, providing the opportunity for the improvement of treatment and care practices.”

The collaboration will provide a formal fellowship framework for pediatric oncology training and mentoring for Egyptian, African and Middle Eastern pediatricians in line with international standards and will create a pool of qualified pediatric oncologists who can ensure continued progress in improving outcomes for children with cancer in this region.

As part of the fellowship, between 2 and 6 pediatric physicians from the Children’s Cancer Hospital Egypt will travel to Boston to work with specialists at Dana-Farber/Children’s Hospital Cancer Center (DF/CHCC).  In addition, DF/CHCC physicians will rotate at the Children’s Cancer Hospital Egypt to train oncologists there in the latest treatments and care techniques.

About the Dana-Farber / Children’s Hospital Cancer Center

Dana-Farber/Children’s Hospital Cancer Center (DF/CHCC) combines the strengths of Dana-Farber Cancer Institute, a world-class cancer institute, and Boston Children’s Hospital, an internationally known pediatric hospital. For over 60 years, these two Harvard Medical School affiliates have provided comprehensive care for children and adolescents with cancer. Committed to conducting research to better understand and treat childhood cancers, DF/CHCC is the Pediatric Oncology Experimental Therapeutics Investigator Consortium’s (POETIC) only Phase I Clinical Trial site in New England, and is home to one of the world’s most sophisticated and accomplished Pediatric Stem Cell Transplantation centers. DF/CHCC also offers comprehensive transitional and long-term survivorship programs to childhood cancer survivors of all ages.